Dow Down 1.29% Nasdaq Down 3.25%

CEL-SCI Corporation (CVM)

-NYSE MKT
0.46 Down 0.02(3.92%) Feb 5, 4:02PM EST
Prev Close:0.48
Open:0.46
Bid:0.45 x 2000
Ask:1.25 x 1000
1y Target Est:3.00
Beta:-1.89955
Next Earnings Date:N/A
Day's Range:0.46 - 0.50
52wk Range:0.36 - 1.23
Volume:499,404
Avg Vol (3m):647,432
Market Cap:60.01M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CVM

Comparison

Symbol% ChgMkt Cap
CVMDown 3.92%60.01M
CLDXDown 1.63%716.17M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):94.88
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-15) :N/A
Quarterly EPS Est (Sep-15) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CEL-SCI Corporation engages in the research and development of drugs and vaccines. The company’s lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback